Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to ad
资讯
2024-11-21
Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programs
Platform w...